Myriad Genetics (MG)
See the following -
Battle Against Breast Cancer Goes Open Source
After a recent U.S. Supreme Court decision shielded Myriad Genetics' genetic data on breast cancer from disclosure, the nonprofit coalition Free the Data! launched a campaign to open troves of molecular information about widespread tumors with the help of big data software outfit Syapse. Read More »
- Login to post comments
How Big Data Is Taking On Breast Cancer — And Big Biotech
Now that the Supreme Court has decided that human genes can’t be patented, a group of researchers is using high-tech data science to better understand the genetic mutations associated with breast cancer. Read More »
- Login to post comments
New Biotech Site Sparks Hope For Cancer Treatments
The latest victory in the Myriad Genetics case in Australia, allowing Myriad Genetics to patent isolated DNA, has sparked new debate over the development of new drugs to treat cancer... Read More »
- Login to post comments
Self-Preservation Chokes Open Science, Kills The Patient
Arguably the one area that stands to benefit the most from open and shared data is science. Yet researchers are reluctant to do it. Why? Because the reward model for scientific discovery is chaining them to dollars they can't pocket otherwise. [...] Read More »
- Login to post comments